Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Steven J. Russell will present the results from the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) on Saturday, April 30, […]
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. · Dr. Ed Damiano, President & CEO of Beta Bionics, is now assuming the role of Founder and Executive Chair · Martha Goldberg Aronson, Board Chair, is now serving as interim CEO […]
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The financing round was co-led by existing Series B and B-2 investors Soleus Capital, Perceptive Advisors, Farallon Capital Management, L.L.C., RTW Investments, LP, and Eventide Asset Management New investor Pura Vida Investments participated […]
The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The iLet® Bionic Pancreas is a pocket-sized, wearable investigational medical device that is designed to autonomously determine and deliver insulin and/or glucagon doses to control blood-glucose levels in people with diabetes and other […]
Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic pancreas system, today announced the appointment of Christy Jones to its Board of Directors. We are delighted to welcome Christy to our Board of Directors, commented Ed Damiano, President and Chief […]
Concord, MA – February 9, 2021 – Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic pancreas system, today announced the appointment of Martha Goldberg Aronson as Chair of its Board of Directors, effective immediately. Ms. Aronson, who joined the Beta Bionics Board as a Director in […]
Concord, MA – December 30, 2020 – Beta Bionics, Inc. — a medical technology company developing the iLet™ the world’s first fully automated bionic pancreas system — today announced that Beth Brooke has been appointed to the Company’s Board of Directors. We are so pleased to have Beth join our Board of Directors at Beta Bionics. […]
West Concord, MA – February 20, 2020 – Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas system called the iLet® today announced that Martha G. Aronson and Sean D. Carney have been appointed to the Company’s Board of Directors effective immediately. We are all […]
The iLet is a pocket-sized, wearable investigational medical device that autonomnously controls blood sugar in people with diabetes and other conditions — it is the world’s first bionic pancreas system FDA’s Breakthrough Device Designation Program provides Beta Bionics with priority review among other benefits related to FDA interaction The iLet Bionic Pancreas System was granted […]
A pilot study performed by researchers at the Massachusetts General Hospital tested autonomous glycemic control using the bionic pancreas system in both insulin-only and bihormonal configurations While using the bionic pancreas, the study subjects experienced improved glycemic control and decreased diabetes-management burden The study suggests that autonomous glycemic control using the bionic pancreas is worthy […]
We are committed to balancing purpose with profit and giving back to society as we fulfill our public benefit mission.
Safety Information – The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/resouces/user-guides, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/resources/safety. DO NOT start to use the iLet Bionic Pancreas System without adequate training. Incorrect use may result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.
Medical Disclaimer – This website is for information only and is not a substitute for medical advice and/or services from a healthcare provider. All personal health care decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs.
Copyright © 2024 Beta Bionics | Privacy Policy | Safety | Terms of Use | Cookies | Patents | Code of Conduct